Brand Name Prescription Drug Antitrust Litigation
(In re Brand Name Prescription Drug Antitrust Litigation, 115 F.3d. 456 (7th Cir. 1997))

Brand-name prescription drug manufacturers and wholesalers allegedly conspired to horizontally fix the price of brand-name prescription drugs by selling the same product to different customers at different prices. This allegedly favored larger clients, such as hospitals, health maintenance organizations, and nursing homes, over smaller patrons, such as neighborhood family pharmacies. A class action was brought into Court and settlements reached $600 Million for 40,000+ independent drug retailers. We assisted drug retailers in filing their settlement claims and this was one of our most successful campaigns.

<< Back to Case List

Testimonials